MAP1A Gene

📖 Wiki Page

gene1077 wordssynced 2026-04-02

MAP1A Gene

Introduction

Map1A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infox-gene"> [@vaillant1999]
<div class="infobox-header">Gene Information</div> [@mandelkow2014]
<table class="infobox-table"> [@dubey2007]
<tr><th>Symbol</th><td><strong>MAP1A</strong></td></tr> [@baas1990]
<tr><th>Full Name</th><td>Microtubule Associated Protein 1A</td></tr> [@kneussel2013]
<tr><th>Chromosome</th><td>15q15.2</td></tr> [@giacomello2020]
<tr><th>NCBI Gene ID</th><td>[4130](https://www.ncbi.nlm.nih.gov/gene/4130)</td></tr> [@guo2023]
<tr><th>OMIM</th><td>[157138](https://www.omim.org/entry/157138)</td></tr> [@wang2006]
<tr><th>Ensembl ID</th><td>[ENSG00000118789](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000118789)</td></tr> [@kanaan2023]
<tr><th>UniProt ID</th><td>[P78527](https://www.uniprot.org/uniprot/P78527)</td></tr>
<tr><th>Protein Length</th><td>2,248 amino acids</td></tr>
<tr><th>Molecular Weight</th><td>~250 kDa</td></tr>
<tr><th>Expression</th><td>Brain-specific, high in hippocampus and cortex</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

...

MAP1A Gene

Introduction

Map1A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Mermaid diagram (expand to render)

Microtubule Associated Protein 1A (MAP1A) is a neuron-specific cytoskeletal protein encoded by the MAP1A gene located on chromosome 15q15.2. MAP1A plays essential roles in microtubule stabilization, axonal transport, synaptic plasticity, and neuronal survival. As a member of the microtubule-associated protein family, MAP1A is critically involved in maintaining neuronal architecture and function, making it a protein of significant interest in neurodegenerative disease research.

Gene Structure and Expression

The MAP1A gene spans approximately 45 kb of genomic DNA and consists of multiple exons that undergo alternative splicing to generate distinct protein isoforms. The gene is expressed predominantly in the central nervous system, with highest expression levels in the hippocampus, cerebral cortex, and cerebellum. Within [neurons](/entities/neurons), MAP1A is enriched in dendrites and axons, where it associates with microtubules to regulate cytoskeletal dynamics and intracellular trafficking.

Regional Expression Patterns

MAP1A expression varies across brain regions and cell types:

[Hippocampus](/brain-regions/hippocampus): High expression in CA1-CA3 pyramidal neurons and dentate gyrus granule cells
[Cortex](/brain-regions/cortex): Strong expression in layer II-III pyramidal neurons
Cerebellum: Abundant in Purkinje cells and granule cells
Basal ganglia: Moderate expression in striatal medium spiny neurons
Brainstem: Present in various nuclei including the locus coeruleus

Protein Structure and Molecular Function

Domain Architecture

MAP1A is a large protein (~250 kDa) characterized by several functional domains:

Microtubule-Binding Domain: The N-terminal region contains repeat sequences that directly bind to microtubules, promoting polymerization and stabilization

LC1 Domain: Light chain 1 binding region that modulates microtubule interactions

Projection Domain: C-terminal region extending from microtubule surfaces, involved in protein-protein interactions

Phosphorylation Sites: Multiple serine/threonine residues that regulate binding affinity and function

Molecular Functions

MAP1A participates in several critical cellular processes:

Microtubule Stabilization: Promotes microtubule assembly and prevents depolymerization, essential for maintaining axonal integrity
Axonal Transport Facilitation: Functions as a molecular scaffold for motor protein complexes, enabling efficient transport of vesicles, organelles, and signaling molecules along microtubules
Synaptic Plasticity: Regulates dendritic spine morphology and synaptic vesicle cycling, influencing learning and memory
Neuronal Development: Supports axonal growth cone guidance and neuronal polarization during development

Role in Neurodegenerative Diseases

Alzheimer's Disease

MAP1A has emerged as a significant player in Alzheimer's disease pathogenesis:

[Tau Protein](/proteins/tau) Interaction: MAP1A shares functional similarities with tau protein and may compensate for tau loss in certain contexts. In AD, tau pathology may disrupt MAP1A-microtubule interactions
Altered Expression: Post-mortem studies show reduced MAP1A expression in AD hippocampus, correlating with cognitive decline
[Amyloid-Beta](/proteins/amyloid-beta) Effects: Aβ oligomers disrupt microtubule function and may downregulate MAP1A expression
Axonal Transport Deficits: Early axonal transport defects in AD involve microtubule dysfunction, in which MAP1A plays a role

Parkinson's Disease

In Parkinson's disease, MAP1A contributes to:

[Alpha-Synuclein](/mechanisms/alpha-synuclein) Transport: MAP1A may facilitate intracellular trafficking of α-synuclein; dysfunction could contribute to protein aggregation
Dopaminergic Neuron Vulnerability: The microtubule cytoskeleton in dopaminergic neurons may be particularly susceptible to MAP1A dysfunction
Axonal Degeneration: Early axonal pathology in PD involves microtubule destabilization

Huntington's Disease

MAP1A alterations in HD include:

Microtubule Dysfunction: Mutant [huntingtin](/proteins/huntingtin-protein) protein impairs microtubule-based transport, affecting MAP1A function
Dendritic Spine Loss: Synaptic pathology in HD involves alterations in MAP1A-mediated plasticity
Energy Metabolism: Axonal transport deficits compound mitochondrial dysfunction in HD

Amyotrophic Lateral Sclerosis

In ALS, MAP1A plays a role in:

Axonal Transport Defects: Early and prominent axonal transport dysfunction in ALS involves microtubule disruption
Motor Neuron Vulnerability: MAP1A dysfunction may contribute to the selective vulnerability of upper motor neurons
Protein Aggregation: Co-localization studies suggest interactions between MAP1A and ALS-associated protein aggregates

Therapeutic Implications

Microtubule-Targeting Strategies

Given the central role of microtubule dysfunction in neurodegeneration, MAP1A-related pathways offer therapeutic opportunities:

Microtubule-Stabilizing Drugs: Compounds like taxols and their derivatives may compensate for MAP1A loss
Small Molecule Modulators: Development of drugs that enhance MAP1A-microtubule interactions
Phosphorylation Modulators: Kinase inhibitors targeting tau kinases (GSK3β, CDK5) may indirectly improve MAP1A function

Gene Therapy Approaches

MAP1A Overexpression: Viral vector-mediated delivery to restore MAP1A levels
Microtubule Motor Enhancers: Gene therapy to boost motor protein function
Combination Therapies: Targeting multiple aspects of cytoskeletal dysfunction

Biomarker Potential

MAP1A in cerebrospinal fluid (CSF) has been investigated as a biomarker:

CSF Levels: Altered MAP1A concentrations in neurodegenerative disease CSF
Diagnostic Utility: Potential for differential diagnosis
Disease Progression: Correlation with disease severity

Background

The study of Map1A Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

Tucker RP, The roles of microtubule-associated proteins in brain morphogenesis: a review (1990)

Vaillant AR, et al, Patterns of microtubule-associated protein expression in the mammalian central nervous system (1999)

Mandelkow E, Mandelkow E, Tau in physiology and pathology (2014)

Dubey J, et al, The microtubule-associated protein MAP1A is involved in neuronal migration and cortical development (2007)

Baas PW, Black MM, Individual microtubules in the axon consist of domains that differ in stability (1990)

Kneussel M, Wagner W, Myosin motors at neuronal synapses: drivers of membrane trafficking and postsynaptic function (2013)

Giacomello E, et al, MAP1A and MAP1B: the forgotten microtubule-associated proteins (2020)

Guo W, et al, The role of microtubule-associated proteins in neurodegenerative diseases (2023)

Wang JZ, et al, Tau phosphorylation, aggregation, and toxicity in neurodegenerative diseases (2006)

Kanaan NM, et al, Axonal degeneration in Alzheimer's disease: unraveling the molecular mechanisms (2023)

Pathway Diagram

The following diagram shows the key molecular relationships involving MAP1A Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

MAP1A Gene

MAP1A Gene

Introduction

Overview

MAP1A Gene

Introduction

Overview

Gene Structure and Expression

Regional Expression Patterns

Protein Structure and Molecular Function

Domain Architecture

Molecular Functions

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Huntington's Disease

Amyotrophic Lateral Sclerosis

Therapeutic Implications

Microtubule-Targeting Strategies

Gene Therapy Approaches

Biomarker Potential

See Also

Background

External Links

References

Pathway Diagram